BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 14533524)

  • 1. Achieving optimal patient outcomes with intravenous iron.
    Colfer M
    Nephrol Nurs J; 2003 Aug; 30(4):449-53; quiz 454-5. PubMed ID: 14533524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing patient concerns about intravenous iron therapy.
    Robbins KC
    Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
    Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous iron for the treatment of anemia in a day hospital: between inflammation and bleeding].
    Méndez Bailón M; Muñoz Rivas N
    Gastroenterol Hepatol; 2010 Dec; 33(10):755-6. PubMed ID: 21051114
    [No Abstract]   [Full Text] [Related]  

  • 6. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
    Schröder O; Schrott M; Blumenstein I; Jahnel J; Dignass AU; Stein J
    Z Gastroenterol; 2004 Aug; 42(8):663-7. PubMed ID: 15314711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy.
    Bowe D
    Nephrol Nurs J; 2008; 35(4):371-7, 394; quiz 378-9. PubMed ID: 18782999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review of the newer intravenous iron therapy options.
    Edwards JH
    Nephrol Nurs J; 2003 Feb; 30(1):70-3. PubMed ID: 12674953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parenteral iron replacement].
    Cynke E
    Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
    [No Abstract]   [Full Text] [Related]  

  • 10. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K
    Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    Kulnigg S; Stoinov S; Simanenkov V; Dudar LV; Karnafel W; Garcia LC; Sambuelli AM; D'Haens G; Gasche C
    Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron among cystic fibrosis patients.
    Hoo ZH; Wildman MJ
    J Cyst Fibros; 2012 Dec; 11(6):560-2. PubMed ID: 22717534
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron replacement and supplementation in patients with chronic kidney disease.
    Wazny LD; Raymond CB
    CANNT J; 2011; 21(4):26-30; quiz 31-2. PubMed ID: 22324122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex.
    Breymann C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S108-9. PubMed ID: 17718296
    [No Abstract]   [Full Text] [Related]  

  • 15. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous iron in a primary-care clinic.
    Maslovsky I
    Am J Hematol; 2005 Apr; 78(4):261-4. PubMed ID: 15795917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
    Krafft A; Breymann C; Huch R; Huch A
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):720-2. PubMed ID: 10949245
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in intravenous iron treatment.
    Marx JJ
    Arzneimittelforschung; 2010; 60(6a):341-4. PubMed ID: 20648925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.